Announcing the Tumor Immunology and Biological Cancer Therapy section (edited by iSBTc) of the Journal of Translational Medicine

doi:10.1186/1479-5876-7-80

Journal of Translational Medicine

Volume 7

Viewing options:

Abstract
Full text
PDF (148KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Romero P
Fox BA

on PubMed

Romero P
Fox BA
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

This article is part of the series Tumor Immunology and Biological Cancer Therapy, edited by iSBTc (Pedro Romero).

Editorial

Announcing the Tumor Immunology and Biological Cancer Therapy section (edited by iSBTc) of the Journal of Translational Medicine

Pedro Romero¹ , Bernard A Fox² and iSBTc Executive Office³

¹Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne branch, University Hospital (CHUV), Lausanne, CH-1011, Switzerland

²Department of Molecular Microbiology and Immunology, Oregon Health and Science University and Robert W Franz Cancer Research Center, Earle A Chiles Research Institute, Portland, OR, USA

³Publications, International Society for Biological Therapy of Cancer, Milwaukee, WI, USA

author email corresponding author email

Journal of Translational Medicine 2009, 7:80doi:10.1186/1479-5876-7-80


Published:	17 September 2009

First paragraph (this article has no abstract)

The International Society for Biological Therapy of Cancer (iSBTc) and BioMed Central are proud and delighted to announce their collaboration in editing a section of the Journal of Translational Medicine devoted to promoting the field of Tumor Immunology and Biological Cancer Therapy.